LegislativeLabs.ai Logo
Legislative Labs
  • Bring the Statehouse to your House.
    • FAQ

      Help using Legislative Labs
    • Support

      Contact us for assistance.
    • Legal

      Terms & Conditions.
    • Privacy

      What we do with your information.
    • Choose Your Plan

      Track, Act, Learn.
    • Analytics

      Intelligence & analytics on previous sessions.
    • Bill History

      Detailed historical bill information.
    • Sponsor Detail

      Detailed sponsor bill performance.
    • About Us

      The reason for Legislative Labs.
    • Classroom

      Bring the Statehouse to the Schoolhouse.
    • BETA

      Session Dashboard

      Live predictions on introduced legislation.
    • BETA

      Bill Drafting

      Predictions on draft legislation.
    • BETA

      Legitron AI

      Legislation made simple with AI.
    • Session Results

      Legislative session analytics.
    • Sign in

SSB 5240

Momentum Bucket Strong Momentum
Legal Title AN ACT Relating to anaphylaxis medications in schools;
Bill Description Concerning anaphylaxis medications in schools.
What this bill does
Powered by Legitron
This bill amends existing law (RCW 28A.210.383 and RCW 28A.210.380) to allow school districts and private schools, including charter schools and state‑tribal compact schools, to maintain a designated supply of epinephrine (including autoinjectors) sized to school enrollment. A licensed prescriber may write prescriptions in the school’s name accompanied by a standing order for administration of school‑supplied, undesignated epinephrine. Donations of epinephrine are permitted if accompanied by a prescription. School nurses and other designated, trained school personnel may use school‑owned epinephrine or any available epinephrine on school property or during sanctioned trips to respond to an anaphylactic reaction, and school nurses or designated personnel may carry school‑owned epinephrine on field trips. If epinephrine that is not school‑owned and not owned by the recipient is administered, the school must reimburse the owner for the cost. The bill changes procedures and creates liability and personnel protections: prescribers and pharmacists who provide epinephrine to a school are not liable for injuries from its administration unless they acted with conscious disregard for safety; school employees and related school entities are not criminally or civilly liable for administering epinephrine when acting in substantial compliance with a student’s prescription or with written school policies aligned with the standing protocol under RCW 28A.210.380. Employees (except those licensed under chapter 18.79 RCW) who have not agreed in writing to administer autoinjectors may file a written refusal and such refusal may not be used as a basis for adverse employment action. The Office of the Superintendent of Public Instruction, in consultation with the Department of Health and with input from specified stakeholders, must develop anaphylaxis policy guidelines for schools, including required training certification (on a Department of Health form to be kept on file), emergency plan and communication procedures, and allergen‑exposure reduction strategies. The bill defines “anaphylaxis” as a severe, potentially life‑threatening allergic reaction. The text references and depends on standing order and protocol provisions in RCW 43.70.827 and RCW 28A.210.380; those provisions and the full standing order/protocol details are not included here. The bill also retains a September 1, 2009 deadline referenced in the amended statute text; the reason for retaining that historical date in this 2025 amendment is not explained in the provided excerpts.
Why it matters
Powered by Legitron
If enacted, schools will be expected to keep a supply of epinephrine (including autoinjectors) sized to their enrollment and allow school nurses or other trained staff to use school‑owned or any available epinephrine to treat anaphylaxis on campus or during trips, even if the student does not have a personal prescription on file. Schools can accept donated epinephrine but it must have a prescription, and districts must reimburse the owner if staff use epinephrine that is not school‑owned and not owned by the person treated. The Office of the Superintendent of Public Instruction and Department of Health will produce model guidelines and a training certification form that schools must use, and staff (except certain licensed health providers) may opt out in writing from administering autoinjectors without fear of job penalty; the bill also limits liability for prescribers, pharmacists, and school employees unless they act with conscious disregard for safety. The groups most affected are school districts and private schools (including charter and state‑tribal compact schools), school nurses and designated trained personnel, and prescribing health professionals and pharmacists. Districts will likely need to budget for buying, storing, and replacing epinephrine or for reimbursing owners, set up training and recordkeeping for certifications, and adopt policies aligned with the new guidelines; their risk of legal exposure for staff administering epinephrine is reduced. The bill leaves out the full text of the referenced standing order and protocol and retains an unexplained 2009 deadline in the amended text, so specific operational details and timing for some requirements are unclear.
Official Documents View Full Bill Text
Follow this bill

SSB 5240 Position - A premium account is required to save position information.

Saving your position first...
Generating hearing testimony using your position and notes...
Generating Bill Comment using your position and notes...

Click to view plans

SSB 5240 Details and Bill Topics

Details

Date Introduced 02/11/2025
Originating Chamber Senate
Biennium 2025-26
Total Campaign Dollars Backing Bill $5,127,320.00

Bill Topics

SSB 5240 Sponsors and Committee Hearings

Sponsors

Senator Wellman (Primary)
Senator Slatter
Senator Boehnke
Senator Hasegawa
Senator Nobles
Senator Stanford
Senator Trudeau
Senator C. Wilson

Committee Hearings

Hearing Senate Early Learning & K-12 Education (Public)
Hearing Senate Early Learning & K-12 Education (Executive)
Hearing House Education (Public)
Hearing House Education (Public)
Hearing House Education (Executive)
Go to SSB 5240 at leg.wa.gov

SSB 5240 Bill Timeline

Strong Momentum
3/3/2026
SRules 3
Rules Committee relieved of further consideration. Placed on second reading.
2/24/2026
SRules 3
Referred to Rules 2 Review.
2/22/2026
SRules 3
ED - Majority; do pass with amendment(s).
2/22/2026
SRules 3
ED - Executive action taken by committee.
1/12/2026
SRules 3
Placed on third reading by Rules Committee.
1/11/2026
SRules 3
By resolution, reintroduced and retained in present status.
4/26/2025
SRules 3
By resolution, returned to Senate Rules Committee for third reading.
3/11/2025
SRules 3
First reading, referred to Education.
3/9/2025
SRules 3
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
3/9/2025
SRules 3
Rules suspended. Placed on Third Reading.
3/9/2025
SRules 3
1st substitute bill substituted.
3/4/2025
SRules 3
Placed on second reading by Rules Committee.
2/11/2025
SRules 3
Passed to Rules Committee for second reading.
2/10/2025
SRules 3
EDU - Majority; 1st substitute bill be substituted, do pass.
1/13/2025
Ssubst for
First reading, referred to Early Learning & K-12 Education.

You have 3 pending action.

Legitron™ is a trademark of Legislative Labs, Inc.

© 2026 - Legislative Labs